Pertuzumab-dpzb is now considered an interchangeable biosimilar to pertuzumab as part of treatment combinations in multiple ...

An analysis of a German multicentre study reveals that women are more likely than men to receive inappropriate diagnostic ...

The EMA’s recommendation follows evidence that the targeted therapy improves progression-free survival in patients whose ...

Karina Volkova trains in a clinic using a temporary permit that expires in 2027, giving her a narrow window to clear all ...

Current strategies to prevent stroke in atrial fibrillation may require a closer look, according to two new studies.

The regulator backed the medicine after phase 3 data showed dramatic reductions in HAE attacks and sustained disease control ...

Avian flu in humans may have made a reappearance after 9 months, according to a press release from the Washington State ...

A trial finds a liberal vs restrictive transfusion threshold for at-risk cardiac patients may improve heart failure and ...

Dr S. Shahzad Mustafa highlights new systemic therapies for urticaria, their impact on quality of life, and the need for ways ...

Social media is accelerating the spread of misleading health information, and public health experts say rebuilding trust will ...

Somatic mutations with effects similar to those seen with VEXAS syndrome are increasingly seen as possible drivers of ...

Weight loss at the time of GLP-1 discontinuation was 10.1% overall, 9.7% for those with T2D, and 11.1% for those without.